InvestorsHub Logo
Followers 789
Posts 123468
Boards Moderated 19
Alias Born 09/05/2002

Re: None

Tuesday, 08/20/2019 8:58:56 AM

Tuesday, August 20, 2019 8:58:56 AM

Post# of 30
ELAN acquires Bayer’s animal-health business for $7.6B in cash+stock:

Elanco Animal Health Incorporated (ELAN) today announced it has entered into an agreement with Bayer AG to acquire its animal health business in a transaction valued at US$7.6 billion. The transaction, which is subject to regulatory approval and other customary closing conditions, creates the second largest animal health leader [behind ZTS]

The transaction will double Elanco’s Companion Animal business, advancing the company’s intentional portfolio mix transformation and creating a balance between its Food Animal and Companion Animal segments. Elanco expects the combined organization to continue to deliver mid-single digit revenue growth…

...Elanco will finance the transaction through both cash and equity. Bayer AG will receive $5.32 billion in cash…and $2.28 billion or approximately 68 million Elanco Animal Health common shares. This represents a 70 percent to 30 percent cash-to-equity mix.

Stock received by Bayer is subject to a 7.5 percent symmetrical collar centered on Elanco’s volume-weighted average price for the 30 trading days ended August 6, 2019 of $33.60.

The transaction is expected to close in mid-2020, subject to regulatory approvals and other customary closing conditions.

At the midpoint of the collar ($33.30), Bayer would receive an 18% equity stake in ELAN, but Bayer intends to monetize these shares in due course.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELAN News